Compare BDTX & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | HYNE |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.7M | 115.7M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | HYNE |
|---|---|---|
| Price | $2.33 | $14.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 597.2K | 25.6K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $13.56 |
| 52 Week High | $4.94 | $14.85 |
| Indicator | BDTX | HYNE |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 51.12 |
| Support Level | $2.19 | $14.17 |
| Resistance Level | $2.86 | $14.50 |
| Average True Range (ATR) | 0.10 | 0.26 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.33 | 43.48 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.